MLB's investigation of Anthony Bosch's Biogenesis clinic in Miami has turned up a name that will resonate across the landscape of baseball: Milwaukee Brewers left fielder Ryan Braun. Braun's name wasn't tied to any specific performance enhancing drugs, but the 2011 NL MVP has been linked with the scarlet letter in the past afterhe failed a drug test prior during the 2011 playoffs and won an appeal due to his urine sample being mishandled.
The Yahoo report about Braun's connection to the clinic does *not* tie him to any specific drugs or regiments, unlike Alex Rodriguez, Gio Gonzalez, and Melky Cabrera, among others. However, Braun's name is written on a list along with Rodriguez, Cabrera, Cesar Carrillo (also linked to PEDs in the initial report) and fellow newbies Francisco Cervelli of the Yankees and Danny Valencia of the Orioles. Also mentioned in the documents obtained by Yahoo are Chris Lyons, one of Braun's attorneys during his successful appeal of the positive drug test following the 2011 season. Braun's positive test was due to an elevated level of testosterone, the same violation that led to the suspensions of Cabrera and Colon during the 2012 season.
This isn't good news for Braun nor Major League Baseball. Braun is one of the league's most marketable stars after a 2012 season that was thought to be clean after his MVP-winning 2011 season that many claimed was tainted after the positive test. Braun, who worked with University of Miami strength and conditioning coach Jimmy Goins (named in the intial Miami New-Times report last week), could see his career absolutely destroyed if his ties to Bosch and the Biogenesis clinic are verified through the league's research. While Rodriguez and Cabrera were enough of a black eye towards baseball, a valid link between Braun and the clinic would be a knockout blow towards baseball's efforts of cleaning up the sport.
UPDATE: Braun released a statement regarding his being linked to Bosch and his clinic, claiming that him and his laywers used Bosch as a reference during his appeal last year due to his familiarity with T/E ratios and the possibility of tampering with a sample. That explanation sounds more plausible than any of the statements revealed by anyone else associated with Biogenetics, but you *know* it's not going to get spun that way.